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Abstract  
Introduction: Mycoplasma species often contaminate cell cultures and other cell-derived biological substances, 
leading to detrimental effects on the host that include changes in growth, morphology, metabolism and protein 
synthesis. In cell cultures, mycoplasma are extracellular parasites, usually attached to the external surface of a 
cell membrane. Many researchers use a mixture of penicillin and streptomycin in the cell culture to prevent 
contamination.  
Material and methods: We prepared cell cultures of lymphocytes from peripheral blood of 12 subjects and 
used micronucleus, assay which is the standard method, for detection of micronuclei in binuclear lymphocytes.  
Results: Use of standard antibiotics does not protect cell cultures against mycoplasma contamination. Penicillin 
has no effect on mycoplasma since mycoplasma lack cell wall. Streptomycin inhibits about half the mycoplasma 
strains but is ineffective against others. In fact, mycoplasma is generally resistant to most antibiotic mixtures 
commonly used in cell culture. We didn’t find any mycoplasma contamination in the cell culture where 
penicillin-streptomycin mixture was absent, but confirmed infection in the culture containing mixture of 
antibiotics.  
Conclusion: Antibiotics and mixture of antibiotics like penicillin-streptomycin mixture does not protect the cell 
culture against mycoplasma contamination. Hence, contamination can spread rapidly to other cell lines through 
aerosol droplet dispersion. 
UDC Classification: 611/612; 577, DOI: http://dx.doi.org/10.12955/cbup.v4.846 
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Introduction 
Most cell culture contaminations result from the accidental introduction of fungi or bacteria, 
sometimes along with mycoplasma. Mycoplasma is a genus of bacteria that is a frequent contaminant 
in cell cultures. The presence of Mycoplasma in a cell culture can change cell physiology, thus 
preventing their appropriate use in experiments. As a result of their small size, Mycoplasma infections 
are very common in cell cultures as they can pass through filters used to prevent contamination and 
can spread to other cultures in a laboratory. Up to 87% of cell lines may be contaminated by 
mycoplasma and this infection can affect virtually any function and activity of eukaryotic cells 
leading to experimental defects and unreliable results (Uphoff & Drexler, 2003, 2005; 
Somasundaram, Nicklas, & Matzku, 1992; Drexler et al., 1994).  
Mycoplasma are the smallest independent, self-replicating organisms identified so far. They lack a 
true cell wall and are therefore deformable under pressure. They contain proteins, RNA, DNA, and 
enzymes. Mycoplasma species often contaminate virus cell-derived biological substances. In cell 
cultures, Mycoplasma develop as extracellular parasites and attach themselves to the surface of the 
cultured cell’s membrane. They can contaminate a variety of eukaryotic cells in culture, leading to 
detrimental host effects that include modifications in cell morphology, growth and metabolism of the 
host cell. They can also influence protein synthesis and virus replication. Because Mycoplasma lack a 
cell wall, antibiotics (such as penicillin) that interfere with formation of cell walls are ineffective 
against them when used at standard concentrations (Nikfarjam and Farzaneh, 2012; Pooja, Rajeev, 
Sunil, & Kumkum, 2013). Mycoplasma originating from human, bovine, and porcine sources are the 
most prevalent, the most common isolates of which are: Acholeplasma laidlawii, Mycoplasma 
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arginini, Mycoplasma fermentans, Mycoplasma hyorhinis, and Mycoplasma orale (Priebe and 
Bromm, 2005).  
Research Goal  
This study aims at elaborating the present knowledge and experience on managing Mycoplasma 
infections while interacting with human tissue culture cells, especially lymphocytes like blood cells. 
Material and Methods  
We prepared the lymphocyte cell cultures from peripheral blood of 12 subjects and used the standard 
method, which is micronucleus assay for detection of micronuclei in binuclear lymphocytes. Venous 
blood sample (3 ml) was collected in heparinized tubes by trained nurses from each individual of both 
exposed and control groups. Blood culture protocol was carried out according to Fenech (2000). 
Blood cultures from the same subject were divided into two groups. In the first set of cultures we 
added penicillin-streptomycin mixture (100 units/mL penicillin and 100 µg/mL streptomycin). In the 
second, we didn’t add antibiotic mixture in order to observe whether the penicillin-streptomycin 
mixtre, which is added to many cell cultures, is necessary for cultivation. The slides were stained by 
2% alkaline Giemsa stain for 8 minutes, washed in distilled water and examined by Leica DM4500 P 
light microscope (×40 and×100). 
Results  
Results showed that in cultures where antibiotic mixture had been added, there was a greater 
Mycoplasma contamination compared to those cultures where antibiotic mixture was absent. Thus, we 
concluded that antibiotics are not necessary for prevention of Mycoplasma. Rather, Mycoplasma 
contamination can be prevented by maintaining good aseptic conditions and lab practices which 
include better techniques, avoiding accidents, cleaning up the work area and surrounding environment 
before and after handling culture and checking for contamination regularly. Figure 1 (a, b, c, d, e) in 
Appendix shows mononuclear and binuclear lymphocytes with Mycoplasma contamination in the 
blood culture (different sizes of cycle formation, dark cytoplasm and large cell wall).  
Other three major sources leading to mycoplasma contamination of cell cultures are: 
 addition of previously infected cells to the culture, 
 addition of medium ingredients from a contaminated cell culture, and  
 contamination by laboratory personnel.  
Contamination can also spread rapidly to other cell lines through aerosol droplet dispersion, especially 
in storage. 
Conclusion 
Mycoplasma contamination presents a major problem during the cultivation of cell cultures. Their 
presence can lead to modification of cell morphology, metabolism and rate of growth. Because of 
their specific structure, Mycoplasma growth in cell cultures can’t be prevented by the use of standard 
antibiotics mixtures. Mycoplasma don’t pose a cell wall and so penicillin has no effect on their growth 
whereas streptomycin can prevent the development of only half of the known mycoplasma strains. 
Other antibiotics, at the concentrations that are routinely used in cell cultures, are generally 
ineffective. The use of standard antibiotics can sometimes mask the Mycoplasma infection by 
minimizing their growth but cannot eliminate them completely. Most efficient way to prevent 
Mycoplasma is the maintenance of strictly aseptic conditions and techniques. Best way to stop 
ongoing contamination is the use of specific antibiotics that can fully eradicate the infection.  
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Appendix 
Figure 1: Slides (a, b, c, d, e) with contamination of mononuclear and binuclear lymphocytes with 
mycoplasma infection  
 
a)        b)  
   
 c)                                                                  d)    
 
e) 
        - binuclear lymphocites,        - mononuclear lymphocytes,       - mycoplasma  
Observed by microscope Leica DM4500 P (×40 and×100) 
Source: Author 
 
